The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA Moves on Peptides: What Compounding Pharmacies Need to Know Warning: BPC 157 is a synthetic peptide and an unapproved drug, often promoted with misleading claims. It is prohibited and on the DoD Prohibited Dietary Supplement Ingredients List. Don't gamble with your Is Your Peptide Store Website FDA Aligned? onPoint Studio Web Design and Development Services When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions